# Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

> **NCT02502110** · PHASE4 · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 346 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DRUG:** rosuvastatin

## Key facts

- **NCT ID:** NCT02502110
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2019-03
- **Final completion:** 2019-06
- **Target enrollment:** 346 (ESTIMATED)
- **Last updated:** 2015-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02502110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02502110, "Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02502110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*